SRI International
-
Mary Lanier talks about SRI Biosciences’ response to the ongoing COVID-19 pandemic
Mary Lanier is a Research Scientist at SRI Biosciences in Menlo Park, CA. Join us to learn how SRI Biosciences is responding to the COVID-19 pandemic—from using existing drug discovery and delivery platforms to innovate vaccines and treatment, to rapid testing capabilities, to developing new vaccines that could protect against future viruses. Learn more about…
-
Alan Braun
Associate Director, Applied Sciences, Advanced Technology and Systems Division
-
Ann Garnier talks about Lisa Health
Ann Garnier is the Founder and CEO of Lisa Health, an SRI Ventures spinoff company. Join us to learn how Lisa Health is transforming menopause and midlife women’s health using the power of technology fused with evidence-based medicine and community. They provide data-driven, science-backed insights and therapeutics to support women across their 30-year midlife journey…
-
Patricia Schank
Computer and Cognitive Scientist, SRI Education
-
Predictive maintenance for Industrial Internet of Things
SRI’s Deep Adaptive Semantic Logic (DASL) performs predictive maintenance to keep IIoT systems online
-
Zafeiria Panou
New Ventures and Commercialization Manager, SRI Ventures
-
Youssef Iguider
Vice President of Business Development & Japan Country Managing Director
-
Yasmina Chitti
Senior DevOps Architect, Artificial Intelligence Center
-
Xiaohe Liu
Research Scientist, Cancer Research Technologies, Discovery Technologies
-
William Mark
Senior Technology Advisor, Commercialization
-
William Kevin Ham
Executive Director, Federal Programs
-
William D. Brubaker
Research Scientist, Rogers Laboratory, Center for Neuroscience